Table 1 Baseline characteristics
From: Role of anticoagulation with apixaban in left-sided atrial tachycardias
Characteristic | Group 1 (n = 213) | Group 2 (n = 226) |
|---|---|---|
Comorbidities | ||
 Hypertension | 145 (68.1%) | 152 (67.3%) |
 Diabetes mellitus | 82 (38.5%) | 97 (42.9%) |
 Hyperlipidemia | 104 (48.8%) | 115 (50.9%) |
 Coronary artery disease | 60 (28.2%) | 72 (31.9%) |
Dosage of apixaban (mg/day) | 5 ± 1 | 5 ± 1 |
Other medications | ||
 Aspirin | 65 (30.5%) | 72 (31.9%) |
 Clopidogrel | 43 (20.2%) | 48 (21.2%) |
 Statins | 102 (47.9%) | 110 (48.7%) |
BMI (kg/m2) | 28.4 ± 3.7 | 29.1 ± 4.0 |
Atrial fibrillation | 26 (12.2%) | 25 (11%) |
Atrial flutter | 7 (3.2%) | 5 (2.2%) |
Age (years) | 62.7 ± 8.5 | 63.5 ± 7.9 |
Gender | ||
 Male | 110 (51.6%) | 120 (53.1%) |
 Female | 103 (48.4%) | 106 (46.9%) |
CHA2DS2-VASc score | 3 ± 1 | 3 ± 1 |